Shelly T. Lee

Ophthalmology

427 S Bernard St
Spokane, WA 99204

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 4 publications

Rituximab therapy for refractory orbital inflammation: results of a phase 1/2, dose-ranging, randomized clinical trial.

Rituximab therapy for refractory orbital inflammation: results of a phase 1/2, dose-ranging, randomized clinical trial.

Journal: JAMA ophthalmology

Published: March 22, 2014

Rituximab therapy for refractory scleritis: results of a phase I/II dose-ranging, randomized, clinical trial.

Rituximab therapy for refractory scleritis: results of a phase I/II dose-ranging, randomized, clinical trial.

Journal: Ophthalmology

Published: September 27, 2013

Adalimumab therapy for refractory uveitis: results of a multicentre, open-label, prospective trial.

Adalimumab therapy for refractory uveitis: results of a multicentre, open-label, prospective trial.

Journal: The British journal of ophthalmology

Published: February 05, 2013

The use of vascular endothelial growth factor inhibitor for choroidal neovascularization complicating posterior uveitis in eyes with fluocinolone acetonide implants.

The use of vascular endothelial growth factor inhibitor for choroidal neovascularization complicating posterior uveitis in eyes with fluocinolone acetonide implants.

Journal: Retinal cases & brief reports

Published: January 01, 2013

Showing 1-4 of 4

Last Updated: 09/26/2026